OSTX - OS Therapies Incorporated

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.95 -0.04 (-2.05%) --- --- --- 0.0 (0.0%) 0.01 (0.51%) 0.0 (0.0%) 0.0 (0.0%)

OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the need for new treatments in cancers of the bone in children and young adults.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.19
Diluted EPS:
-0.19
Basic P/E:
-10.0526
Diluted P/E:
-10.0526
RSI(14) 1m:
0.0
VWAP:
1.91
RVol:
0.5064

Events

Period Kind Movement Occurred At
1m Price decrease 1m 1.9 -0.03 (-1.55%) Oct 15 09:51

Related News